ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 4859

Journal of Addiction Research & Therapy received 4859 citations as per Google Scholar report

Journal of Addiction Research & Therapy peer review process verified at publons
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • SafetyLit
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page

Comorbid depression and alcohol dependence: A review

2nd International Conference and Exhibition on Addiction Research & Therapy

Souravh Bais

AcceptedAbstracts: J Addict Res Ther

DOI: 10.4172/2155-6105.S1.013

Abstract
P atients who are seen in clinical practice commonly have multiple problems, yet efficacy data often reflect treatment of a single illness. Thus, it is useful to know how standard treatment approaches need to be modified for comorbid disorders. This article briefly describes prevalence, assessment, clinical features, and treatment of comorbid major depression and alcohol dependence. Comorbid is characterised by symptoms of both depression and anxiety. Patients who have comorbid depression and anxiety have higher severity of illness, higher chronicity and significantly greater impairment in work functioning, psychosocial functioning and quality of life than patients only suffering from single disease like depression or anxiety. One of the most important clinical reasons to screen for comorbidity is that unrecognized depression/anxiety comorbidity is associated with an increased rate of psychiatric hospitalization and an increased rate of suicide attempts. Sometimes physicians are not exactly aware of the comorbidity because the symptoms of depression and anxiety are common pathophysiologically. Both major depression and alcohol dependence carry a significant risk for the development of the other. Severity in one disorder is associated with severity in the other. Moreover, alcohol dependence prolongs the course of depression, and persistent depression during abstinence from alcohol is a risk factor for relapse to heavy drinking. Thus, logic dictates that both disorders be identified and managed concurrently and aggressively. Integrated psychosocial outpatient treatment programs and the ability to treat alcohol and depression simultaneously have reinforced the need to revisit the traditional management of comorbid major depression and alcohol dependence more formally
Biography
Souravh Bais has completed his M. Pharmacy at the age of 23 years from RGPV University. He is the Assit. Prof. of Pharmacology, at Rayat College of Pharmacy, Railmajra, Near Ropar, Nawanshahr-144533, Punjab, India. He has published papers in both national and international reputed journals.
Relevant Topics
Top